ArticleApplied biochemistry and biotechnology2026
Tandem Repeat Gene Strategy for High-Yield Production and Functional Evaluation of Bioactive Wheat Oligopeptides.
Article in Applied biochemistry and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Bioactive wheat peptides are promising functional ingredients, yet their industrial production remains constrained by low yields, product heterogeneity, and poor scalability associated with conventional enzymatic hydrolysis and chemical synthesis. Here, we report a tandem-repeat gene strategy for the scalable biosynthesis of the representative wheat peptide YDW (Tyr-Asp-Trp-Pro-Gly-Gly-Arg-Asn). By integrating codon optimization with engineered pepsin-cleavable linkers, high-molecular-weight precursor proteins were efficiently expressed in Escherichia coli and subsequently converted into homogeneous target peptides through site-specific enzymatic processing. Systematic evaluation of repeat architectures identified the 24-repeat construct as optimal, reflecting a balance between gene length, mRNA stability, and translational burden. This system achieved peptide yields of up to 5 g/L in a 700 L fermentation process, demonstrating strong scalability. The resulting peptides exhibited high purity and correct molecular weight, as confirmed by HPLC and LC-MS/MS analyses. Functional assays further showed that YDW significantly enhanced cellular collagen I expression by over 240% relative to controls, supporting its potential in anti-photoaging and tissue repair applications. This work establishes a generalizable and scalable platform for the biomanufacturing of cereal-derived bioactive peptides, providing a practical alternative to conventional methods and enabling future studies on peptide structure-function relationships and industrial applications.
Indexed as
Identifiers
42397525What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.